Study of Clotrimazole and Hydroxyurea in Patients With Sickle Cell Syndromes

NCT00004404 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Sickle Cell Anemia

Interventions

DRUG: clotrimazole
DRUG: hydroxyurea

Sponsor

Boston Children's Hospital